# A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic Procedures

> **NCT06216444** · PHASE4 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 240 (estimated)

## Conditions studied

- Sedation in Non-intubated Diagnostic and Therapeutic Procedures

## Interventions

- **DRUG:** Remimazolam Tosilate for Injection
- **DRUG:** Remimazolam Tosilate for Injection

## Key facts

- **NCT ID:** NCT06216444
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01
- **Primary completion:** 2024-03
- **Final completion:** 2024-03
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2024-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06216444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06216444, "A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic Procedures". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06216444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*